Wednesday, May 13, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Financial Markets

Venture Growth is not Healthcare Growth

Daily Remedy by Daily Remedy
March 20, 2022
in Financial Markets
0
Venture Growth is not Healthcare Growth

Move fast and break things – this is the famous motto of Facebook’s founder and CEO, Mark Zuckerberg. It worked well, until it did not, when they moved too fast and broke the public’s trust.

This is the nature of growth in business; it is subject to different levers and constraints that change as a company advances from startup to grownup. Each industry is different. The trajectory of growth in the hospitality industry is different from that of the healthcare industry. This may sound obvious enough at face value, but many hard truths turn into convenient lies when they are implicitly assumed to be true.

Take, for example, the venture capital growth model in healthcare. We love it, to the point of obsessing over it. Every proposed digital interface is anointed the savior of healthcare, the one missing tool that will solve a pressing issue in dire need of saving. But like most fairy tales, these stories prove too good to be true.

No app, digital platform, or single innovation will save healthcare. Growth as we understand it in venture capital does not apply to medicine. Healthcare is hopelessly decentralized for a reason, the trajectories for growth present too many constraints for unbridled expansion. A healthcare system in Chippewa Falls, WI is different from one in downtown Memphis, TN.

This is what many venture capitalists advocating for a growth at all costs mindset in healthcare fail to understand. In medicine, there is more that divides than unites patients. Patient care cannot grow beyond a certain point without adapting to the unique needs of different patient populations.

In contrast, growth in the digital consumer space has few constraints and an abundance of levers of growth. One tweet from a celebrity can send an app in the digital consumerism space from startup oblivion to the center of all public conversation. But this is the digital space. Healthcare is quite the opposite, with few levers and many constraints – even in the digital healthcare space.

But we seem to overlook these differences, ignoring the constraints and emphasizing the levers in healthcare. This is why we see commercials with celebrities endorsing healthcare systems. They appear promising, but they do little to move the needle. In healthcare, a patient finds little in common with a celebrity.

Since a consumer and a patient think differently, the associated behavior is different as well. These subtle differences dictate the levers and constraints of growth. After all, a business is nothing more than the collective behavior of its patrons. And when we fail to understand these differences, we assume that we can replicate growth trajectories from the venture world into healthcare. This initial misunderstanding creates erroneous logic that leads to misguided solutions.

We think healthcare is a problem of access, that if we improve access to care, then we can improve patient outcomes. But it is a problem of limited supply; we have too few clinicians in healthcare able to address the clinical problems of so many. But in conflating demand with supply, we create solutions that fail to address existing problems, while investing in nonexistent problems healthcare never had to begin with.

These solutions fail because we fail to understand the issue at hand. Healthcare is not a digital consumerism space, and improving healthcare digitally does not mean improving healthcare through means of consumerism like in other industries.

No healthcare venture capitalist will admit as much. They have too much to gain. But the returns garnered by an investor are not from successes gleaned in patient outcomes, but in returns on financial outcomes. Again the growth trajectory is different.

If we want to improve healthcare, then we need models that improve on patient care. It is that direct, but that complicated. The growth trajectory for improving patient outcomes is quite cumbersome – we have physicians delegating to medical assistants, we have pharmacists parlaying physicians against insurance plans, and we have patients waiting to be seen, and once seen, waiting to be understood – until the process is repeated over again.

This is the complex nature of healthcare. It has its own growth trajectory, and it cannot be replicated by other models of growth. And truthfully, we still do not fully appreciate what it takes to both improve clinical care and scale that quality of care consistently. Only after we understand what growth truly means in healthcare, can we develop scalable solutions.

Perhaps then we will be able to capitalize on more than the financial upside in healthcare, and actually address what matters – the patient outcomes.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • The 340B Coalition

    The 340B Coalition

    0 shares
    Share 0 Tweet 0
  • The Rebate That Ate the List Price

    0 shares
    Share 0 Tweet 0
  • Force of Impact in a Tackle

    0 shares
    Share 0 Tweet 0
  • The Number Nobody Publishes

    0 shares
    Share 0 Tweet 0
  • How Smart Kitchen Renovations Support Healthy Habits and Wellness

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy